TrademarkIQ íconeTrademarkIQ
Voltar para busca
Dado oficial do USPTO

THINC-IT

Sabia que essa marca já está registrada no Estados Unidos?

Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.

Active USPTO registrationTipo: VerbalEscritório: US

Snapshot rápido

THINC-IT

ST13

US500000079213637

Classe

5, 9, 10, 42, 44

Pedido

79213637

Registro

5516053

Diagnóstico de risco e oportunidade

Leitura executiva para decisão de naming, protocolo e monitoramento.

Atenção: há risco ativo

Situação USPTO

Active USPTO registration

Tipo de processo

Pedido e registro

Eventos registrados

43

Atualização mais recente

14/02/2026

Classificação

Registrada

Tipo de marca

Verbal

Classes Nice

5, 9, 10, 42, 44

Data de depósito

31/01/2017

Data de registro

17/07/2018

Data de expiração

-

Ação recomendada

Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.

Próximo passo

Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.

Dados completos do processo

Campos estruturados da autoridade responsável e do histórico oficial.

Data da situação

13/06/2025

Última transação

14/02/2026

Escritório responsável

United States Patent and Trademark Office

Código da situação

707

Cadastro oficial

Principal Register

Código do desenho

4

Tipo de titular

99

Localização do titular

Valby, DK

Examinador

BENMAMAN, ALICE

Localização atual

Historical data usage

Titulares e representantes

Titulares

H. Lundbeck A/S
H. Lundbeck A/S

Representantes

Maren C. Perry King & Spalding LLP

Classificação técnica

Classes Nice

Classe 5Classe 9Classe 10Classe 42Classe 44

Códigos Vienna

Sem códigos Vienna disponíveis.

Produtos e serviços

Classe 5

[ Vaccines; pharmaceutical preparations and substances for the prevention and treatment of disorders and diseases in, generated by or acting on the central nervous system; pharmaceutical preparations and substances acting on the central nervous system; central nervous system stimulants; pharmaceutical preparations and substances for the prevention and treatment of psychiatric and neurological disorders and diseases; pharmaceutical preparations and substances for the prevention and treatment of Alzheimer's disease and disorder, stroke, depression, cognitive impairment, mood disorders, psychosis, anxiety, epilepsy, sclerosis, porphyria, Huntington's disease and disorder, insomnia, Parkinson's disease and disorder, schizophrenia, bipolar disorder and disease, ADHD, cancer, pain, alcoholism and chemical dependency; medical diagnostic agents, reagents, preparations and substances for medical purposes; pharmaceutical preparations for treatment of cognitive disorders and diseases ]

Classe 9

Downloadable electronic publications in the nature of [ books, reports, ] brochures, [ booklets, ] leaflets, including patient information leaflets, [ magazines, journals, ] teaching and educational material in the field of research and development, science, clinical studies, tests and trials, diagnostic, medicine, pharmaceuticals, disorders, diseases, treatment and prevention [ ; computer application software for mobile devices, namely, software for providing information and interaction in the field research and development, science, clinical studies, tests and trials, diagnostic, medicine, pharmaceuticals, disorders, diseases, treatment and prevention ]

Classe 10

[ Medical diagnostic apparatus and instruments for use in diagnosing, managing, monitoring, assessing, controlling and examining symptoms, signs and effects of Alzheimer's disorder and disease, stroke, depression, cognitive impairment, mood disorders, psychosis, anxiety, epilepsy, sclerosis, porphyria, Huntington's disease and disorder, insomnia, Parkinson's disease and disorder, schizophrenia, bipolar disorder and disease, ADHD, cancer, pain, alcoholism and chemical dependency; injection devices for pharmaceuticals, syringes and needles for injections and medical purposes; integrated medical systems, namely, medical diagnostic imaging apparatus and software sold as a unit therewith for managing, measuring, collecting, storing, monitoring, assessing, controlling and examining patient data and information captured by the medical system in web-based physical, psychological and neurological examinations conducted at a distance and at a clinic; medical apparatus and units for dosage, measuring and monitoring, namely, drug delivery devices and systems ]

Classe 42

[ Pharmaceutical research and development; scientific and technological services, namely, research in the field of medical disorders, diseases, treatment and prevention; scientific and technological services, namely, research in the field of the central nervous system and central nervous system related disorders, diseases and pharmaceuticals; medical research and tests in the field of psychology and neurology; conducting clinical research and tests in the field of psychology and neurology; medical diagnostic research and tests namely, conducting clinical trials for others ]

Classe 44

[ Medical services, therapeutic services and healthcare services, namely, clinical healthcare services; providing medical and healthcare information; services in the field of psychiatry and psychology and medical treatment of central nervous system diseases and disorders; medical advice related to medical and pharmaceutical preparations and substances; healthcare and medical services related to central nervous system and brain disorders, diseases and pharmaceuticals; providing medical and medicinal information in the field of diagnostic, medicine, pharmaceuticals, disorders, diseases, treatment and prevention; providing on-line medical data and analyses designed to provide patients and clients customized information, namely, regarding calculation of medical dose, diagnosis, and therapeutic issues and medical management ]

Publicações

Histórico de despachos e eventos da marca no USPTO.

43 publicações encontradas

INPR

PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED

13/02/2026

NA71

NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED

13/06/2025

71.P

REGISTERED - PARTIAL SEC 71 ACCEPTED

13/06/2025

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

13/05/2025

ES71

TEAS SECTION 71 RECEIVED

15/01/2025

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

22/03/2024

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

22/03/2024

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

22/03/2024

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

22/03/2024

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

22/03/2024

REM3

COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED

17/07/2023

FINO

FINAL DECISION TRANSACTION PROCESSED BY IB

16/11/2018

FICS

FINAL DISPOSITION NOTICE SENT TO IB

29/10/2018

FIMP

FINAL DISPOSITION PROCESSED

29/10/2018

FICR

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

17/10/2018

R.PR

REGISTERED-PRINCIPAL REGISTER

17/07/2018

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

01/05/2018

PUBO

PUBLISHED FOR OPPOSITION

01/05/2018

GPNX

NOTIFICATION PROCESSED BY IB

27/04/2018

OPNS

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

11/04/2018

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

11/04/2018

OP2R

NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB

11/04/2018

FIXD

ELECTRONIC RECORD REVIEW COMPLETE

26/03/2018

ERRR

ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED

23/03/2018

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

20/03/2018

XAEC

EXAMINER'S AMENDMENT ENTERED

20/03/2018

GNEN

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

20/03/2018

GNEA

EXAMINERS AMENDMENT E-MAILED

20/03/2018

CNEA

EXAMINERS AMENDMENT -WRITTEN

20/03/2018

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

23/02/2018

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

23/02/2018

ALIE

ASSIGNED TO LIE

22/02/2018

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

13/02/2018

RFNT

REFUSAL PROCESSED BY IB

01/09/2017

RFCS

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

15/08/2017

RFRR

REFUSAL PROCESSED BY MPU

14/08/2017

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

11/08/2017

MAFR

APPLICATION FILING RECEIPT MAILED

11/08/2017

CNRT

NON-FINAL ACTION WRITTEN

10/08/2017

DOCK

ASSIGNED TO EXAMINER

07/08/2017

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

07/08/2017

LIMI

LIMITATION FROM ORIGINAL APPLICATION ENTERED

04/08/2017

REPR

SN ASSIGNED FOR SECT 66A APPL FROM IB

03/08/2017

Proteção contínua da sua marca

Seja avisado a cada novo depósito que ameace THINC-IT ou a sua marca.

Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.